NanoVibronix “achieves goals” of US trial pilot phase with UroShield
NanoVibronix has completed the first phase of a randomised control trial with UroShield, the company’s disposable ultrasound device designed to…
Infectious Diseases
-
-
Flu diagnostic test snapshot amid mounting burden on the NHS
Data from England’s National Health Service (NHS) shows that flu cases in the country have soared over the past month,…
-
Hologic agrees with CDC to develop reagents for H5N1 bird flu testing
Hologic has agreed with the US Centers for Disease Control and Prevention (CDC) to create analyte-specific reagents (ASRs) that could…
-
Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment
Spectral Medical will have to wait to submit an application to the US Food and Drug Administration (FDA) for its…
-
Ondine accelerates pivotal antimicrobial trial after $11m financing
Ondine Biomedical will initiate a Phase III trial of its light-activated antimicrobial technology to reduce healthcare-associated infections (HAIs) early after…
-
Healgen’s dual flu and Covid-19 test receives FDA authorisation
Healgen has received the US Food and Drug Administration’s (FDA) marketing authorisation for its Rapid Check Covid-19/Flu A&B Antigen Test.…
-
Spectral Medical’s revenue up 54% as company eyes Tigris trial completion
Spectral Medical has reported a 54% rise in revenue for the second quarter as the Canadian company looks ahead to…
-
Inside Canary Wharf’s infectious disease testing facility
Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building that…
-
FDA grants EUA for Watmind USA’s SpeedySwab Covid + FLU A&B self-test
Watmind USA has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for its SpeedySwab…
-
The impact of congenital cytomegalovirus
Cytomegalovirus (CMV) is a common virus that typically causes mild or asymptomatic infections in people with healthy immune systems. However,…
